A single blood test could reveal whether an otherwise healthy person is unusually likely to die of pneumonia or sepsis within the next 14 years. Based on an analysis of 10,000 individuals, researchers have identified a molecular byproduct of inflammation, called GlycA, which seems to predict premature death due to infections.The findings suggest that high GlycA levels in the blood indicate a state of chronic inflammation.
http://www.sciencedaily.com/releases/2015/10/151022124339.htm
Biomarker for premature death
22 octubre 2015
Volver